Skip to main content
. 2017 Apr 20;7(5):432–440. doi: 10.1177/2192568217699384

Table 4.

Univariate Analysis of Mortality for ASD Surgery.a

Characteristic Total (N = 5803) No Mortality (N = 5775) Mortality (N = 29) P
Demographics
 Age
  <51 21.6% 21.7% 6.9% .157
  51-60 26.0% 26.0% 20.7%
  61-70 31.7% 31.7% 37.9%
  71-80 17.5% 17.5% 31.0%
  >80 3.2% 3.2% 3.5%
 Female 59.0% 48.3% .240
 Race
  African American 7.6% 7.6% 3.5% .212
  Caucasian 81.1% 81.2% 75.9%
  Hispanic 3.8% 3.8% 3.5%
  Otherb 7.5% 7.4% 17.2%
 BMI, kg/m2
  Nonobese 58.1% 55.2% 58.1% .840
  Obese class I (30.0-34.9) 23.8% 23.8% 27.6%
  Obese class II (35.0-39.9) 11.3% 11.3% 13.8%
  Obese class III (≥40) 6.7% 6.7% 3.5%
 ASA 3 or 4 53.2% 52.9% 96.6% <.0001
 Diabetes
  Nondiabetic 85.4% 85.5% 69.0% .028
  Insulin dependent 4.7% 4.7% 6.9%
  Insulin independent 9.9% 9.8% 24.1%
 Dyspnea 6.0% 6.0% 3.5% .564
 Dependent functional Health status prior to surgery 4.6% 4.5% 13.8% .012
 Steroid use 3.8% 3.8% 6.9% .376
 Recent weight loss 0.2% 0.2% 3.5% <.0001
Comorbidities
 Ventilator dependent 0.2% 0.2% 3.5% <.0001
 COPD 4.9% 4.9% 13.8% .027
 CHF 0.4% 0.4% 3.5% .011
 Hypertension requiring medication 54.5% 54.4% 69.0% .117
 Renal failure 0.1% 0.1% 0.0% .851
 Dialysis Use 0.3% 0.3% 3.5% .004
 Bleeding disorder 1.2% 1.2% 0.0% .551
 Preoperative blood transfusion 0.2% 0.2% 0.0% .798
Operative variables
 Operative time >4 hours 47.9% 47.8% 72.4% .008
 Total RVU, mean (SD) 73.4 (28.8) 73.3 (28.7) 93.0 (33.8) .0002
 Inpatient 96.4% 96.4% 100.0% .294
 Procedure length
  Long 63.0% 62.9% 93.1% .001
  Short (≤3 levels) 37.0% 6.9% 37.1%
 Procedure approach
  Anterior 39.6% 39.7% 20.7% .042
  Posterior 56.7% 56.6% 79.3%
  Combined 3.7% 3.7% 0.0%
 Procedure subtypes
  Insertion of intervertebral device 41.5% 41.6% 37.9% .693
  Osteotomy 14.4% 14.4% 17.2% .665
  Bone grafting 69.8% 69.8% 58.6% .190
  Fusion to pelvis 8.3% 8.3% 17.2% .0805

Abbreviations: ASD, adult spinal deformity; BMI, body mass index; ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; RVU, relative value unit.

aBoldface indicates significant at P < .05.

bOther race includes Native Hawaiian, Pacific Islander, Asian, American Indian, or Alaska Native.